Dear Mr. President and Director Navarro, We write in support of the Administration prioritizing incentives for onshoring certain manufacturing, including pharmaceutical products and ingredients. As you well know, about 72 percent of pharmaceutical ingredients supplying the United States are not manufactured here. That is an alarming percentage, especially considering we are fighting a global pandemic. … Continue reading Coalition Letter supporting efforts to encourage pharmaceutical firms to move operations to the United States